# The Effectiveness Of Intravenous TXA on Reducing Perioperative Blood Loss For Patients Undergoing PAO

> **NCT03823417** · PHASE4 · WITHDRAWN · sponsor: **Boston Children's Hospital**

## Conditions studied

- Bleeding

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03823417
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-07
- **Primary completion:** 2019-07-23
- **Final completion:** 2019-07-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigators decided not to begin the study.
- **Last updated:** 2019-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03823417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03823417, "The Effectiveness Of Intravenous TXA on Reducing Perioperative Blood Loss For Patients Undergoing PAO". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03823417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*